SCHEMBL18200617

SCHEMBL18200617

c1cc(-c2cc(-c3ccncc3)nc(-c3ccncc3)c2)cc(-c2cc3c(-c4ccc5ccccc5c4)nc4ccccc4c3c3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ MAPK9 P45984 3/20 0.40
▸ MAPK10 P53779 3/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ MAPK8 P45983 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ DHODH Q02127 1/20 0.39
▸ ACACA Q13085 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPK14 Q16539 4/20 0.37
▸ CSNK1D P48730 3/20 0.37
▸ MAPK11 Q15759 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200616 1.00 KDM4E (0.46) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18200778 0.97 KDM4E (0.47) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18200815 0.95 ACACA (0.41) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL18200663 0.94 KDM4E (0.43) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18200688 0.94 ACACA (0.41) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL18201204 0.93 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18201095 0.93 KDM4E (0.48) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18200690 0.91 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDMAPK9
SCHEMBL18200644 0.90 CYP11B1 (0.47) CYP2C9LMNADHODHNPC1RAB9A
SCHEMBL18200634 0.90 CYP11B1 (0.47) CYP2C9LMNADHODHNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 — — US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 KDM4E 1977/4885ALDH1A1 85/4885MAPT 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback